RNF112 and neoplasm: In vivo methodologies required generation of 4T1 cells engineered to express blue fluorescent protein (BFP) to enable the purification of-4T1-BFP+ cells from the heterogenous tumor environment using fluorescently activated cell sorting (FACS) (Supplementary Figure S1).